AI Identifies New Antibiotics for Drug-Resistant Gonorrhoea

A machine-learning model has identified novel antibiotic compounds capable of combating drug-resistant strains of Neisseria gonorrhoeae. The research, published online in Nature on June 24, 2026, utilized a deep learning approach to screen thousands of potential drug candidates.

The bacterium Neisseria gonorrhoeae has evolved resistance to nearly all currently available antibiotics, posing a significant global public health threat. This widespread resistance has made gonorrhoea increasingly difficult to treat, leading to a rise in untreatable infections. The new AI-driven screening method offers a promising avenue for discovering effective treatments.

The AI model was trained on known antibiotic structures and their effectiveness against various bacteria. It then analyzed a library of chemical compounds, predicting which ones might inhibit the growth of Neisseria gonorrhoeae, particularly its resistant strains. This computational approach significantly accelerates the drug discovery process compared to traditional laboratory methods.

Initial laboratory tests confirmed that several of the AI-identified compounds demonstrated potent activity against Neisseria gonorrhoeae, including strains that are resistant to existing treatments like ceftriaxone and azithromycin. Further research is ongoing to optimize these compounds and assess their safety and efficacy in clinical trials. The development marks a critical step in addressing the growing challenge of antibiotic resistance.